News Conference News STS 2025 Transplant Recipients on Medicaid More Likely to Develop Allograft Vasculopathy Yael L. Maxwell January 30, 2025
News Conference News STS 2025 STS Experts Tackle Need For Women-Only Trials in Surgery Yael L. Maxwell January 29, 2025
News Conference News PCR London Valves 2024 Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice Michael O'Riordan November 25, 2024
News Conference News AHA 2024 Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F Michael O'Riordan November 16, 2024
News Features GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix? Todd Neale November 13, 2024
News Conference News VIVA 2023 ‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion L.A. McKeown November 03, 2023
News Conference News HFSA 2023 ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT Yael L. Maxwell October 16, 2023
News Daily News US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy Michael O'Riordan June 19, 2023
News Daily News First-Ever Cardiac Surgery Trial in Women Poised to Launch: ROMA-Women Shelley Wood April 07, 2023
News Daily News For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread Michael O'Riordan January 30, 2023
News Daily News More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials Michael O'Riordan October 28, 2022
News Daily News COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK Michael O'Riordan September 15, 2022
News Features Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle Shelley Wood October 08, 2021
News Daily News Women Stand to Gain the Most From Standardized STEMI Protocols Michael O'Riordan September 30, 2021
News Daily News Endpoint Reporting in Medical Journals Needs to Be Revamped: Review Michael O'Riordan August 17, 2021
News Daily News Patient-Reported Outcomes Beat NYHA Class for Tracking Gains in HFrEF L.A. McKeown March 25, 2021
News Daily News Hospitals Likely Miscount True STEMIs, Analysis Suggests Michael O'Riordan February 19, 2021